Showing 1 - 5 results of 5 for search 'Thailin Lao', query time: 0.03s Refine Results
  1. 1
    Transient Expression in HEK-293 Cells in Suspension Culture as a Rapid and Powerful Tool: SARS-CoV-2 N and Chimeric SARS-CoV-2N-CD154 Proteins as a Case Study

    Transient Expression in HEK-293 Cells in Suspension Culture as a Rapid and Powerful Tool: SARS-CoV-2 N and Chimeric SARS-CoV-2N-CD154 Proteins as a Case Study by Thailin Lao, Omar Farnos, Alexi Bueno, Anays Alvarez, Elsa Rodríguez, Julio Palacios, Kathya Rashida de la Luz, Amine Kamen, Yamila Carpio, Mario Pablo Estrada

    Published 2023-11-01
    Get full text
    Article
  2. 2
    Screening and selection strategy for the establishment of biosimilar to trastuzumab-expressing CHO-K1 cell lines

    Screening and selection strategy for the establishment of biosimilar to trastuzumab-expressing CHO-K1 cell lines by Thailin Lao-Gonzalez, Alexi Bueno-Soler, Arnelys Duran-Hernandez, Katya Sosa-Aguiar, Luis Eduardo Hinojosa-Puerta, Tays Hernandez-Garcia, Kathya Rashida de la Luz-Hernandez, Julio Palacios-Oliva, Tammy Boggiano-Ayo

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19

    Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate... by Thailin Lao, Ileanet Avalos, Elsa María Rodríguez, Yasser Zamora, Alianet Rodriguez, Ailyn Ramón, Yanitza Alvarez, Ania Cabrales, Ivan Andújar, Luis Javier González, Pedro Puente, Cristina García, Leonardo Gómez, Rodolfo Valdés, Mario Pablo Estrada, Yamila Carpio

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19.

    Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate... by Thailin Lao, Ileanet Avalos, Elsa María Rodríguez, Yasser Zamora, Alianet Rodriguez, Ailyn Ramón, Yanitza Alvarez, Ania Cabrales, Ivan Andújar, Luis Javier González, Pedro Puente, Cristina García, Leonardo Gómez, Rodolfo Valdés, Mario Pablo Estrada, Yamila Carpio

    Published 2023-01-01
    Get full text
    Article
  5. 5
    Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate

    Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate by Ileanet Ávalos, Thailin Lao, Elsa María Rodríguez, Yasser Zamora, Alianet Rodríguez, Ailyn Ramón, Gilda Lemos, Ania Cabrales, Monica Bequet-Romero, Dionne Casillas, Ivan Andújar, Luis Ariel Espinosa, Luis Javier González, Yanitza Alvarez, Yamila Carpio, Mario Pablo Estrada

    Published 2022-06-01
    Get full text
    Article

Search Tools: